{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:13:16Z","timestamp":1781035996421,"version":"3.54.1"},"reference-count":40,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s298670","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T20:40:32Z","timestamp":1616013632000},"page":"611-623","source":"Crossref","is-referenced-by-count":15,"title":["Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4\/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment"],"prefix":"10.2147","volume":"Volume 15","author":[{"given":"Kathleen","family":"Beusterien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine C","family":"Maculaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Hallissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Gaschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lou","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest H","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341\u20131352. doi:10.1016\/S0140-6736(15)61074-1","DOI":"10.1016\/S0140-6736(15)61074-1"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","volume":"62","author":"Osborne","year":"2011","journal-title":"Annu Rev Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0233571","DOI":"10.1371\/journal.pone.0233571","volume":"15","author":"Zheng","year":"2020","journal-title":"PLoS One"},{"key":"ref6","unstructured":"Pfizer. A study of palbociclib in addition to standard endocrine treatment in hormone receptor positive Her2 normal patients with residual disease after neoadjuvant chemotherapy and surgery (PENELOPE-B). NLM identifier: NCT01864746. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01864746. Accessed December 4, 2020."},{"key":"ref7","unstructured":"Eli Lilly and Company. Endocrine therapy with or without abemaciclib (LY2835219) following surgery in participants with breast cancer (monarchE). NLM identifier: NCT03155997. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03155997. Accessed December 4, 2020."},{"key":"ref8","unstructured":"Novartis Pharmaceuticals. A trial to evaluate efficacy and safety of ribociclib with endocrine therapy as adjuvant treatment in patients with HR+\/HER2- early breast cancer (NATALEE). NLM identifier: NCT03701334. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03701334. Accessed December 4, 2020."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","volume":"17","author":"Cristofanilli","year":"2016","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa1607303","volume":"375","author":"Finn","year":"2016","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1200\/JCO.2017.75.6155","volume":"35","author":"Goetz","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMoa1609709","volume":"375","author":"Hortobagyi","year":"2016","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1200\/JCO.2017.73.7585","volume":"35","author":"Sledge","year":"2017","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1758835918793326","DOI":"10.1177\/1758835918793326","volume":"10","author":"Thill","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2020.03.001","author":"Ball","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1634\/theoncologist.2017-0072","volume":"22","author":"Loibl","year":"2017","journal-title":"Oncologist"},{"key":"ref17","unstructured":"GoodRx.com [homepage on the internet]. Breast Cancer Medications; 2020. Available from: https:\/\/www.goodrx.com\/breast-cancer\/drugs. Accessed September 20, 2020."},{"key":"ref18","author":"Schaecher","year":"2018","journal-title":"J Hematol Oncol Pharm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40271-019-00375-w","volume":"12","author":"Guerra","year":"2019","journal-title":"Patient"},{"key":"ref20","first-page":"386","volume":"7","author":"daCosta DiBonaventura","year":"2014","journal-title":"Am Health Drug Benefits"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2147\/IJWH.S31331","volume":"4","author":"Beusterien","year":"2012","journal-title":"Int J Womens Health"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.2147\/PPA.S254934","volume":"14","author":"Maculaitis","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"ref24","first-page":"795","volume":"10","author":"Crivera","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40258-013-0028-y","volume":"11","author":"Hauber","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"ref26","volume-title":"Stated Choice Methods: Analysis and Application","year":"2000"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41523-018-0097-z","volume":"5","author":"Johnston","year":"2019","journal-title":"NPJ Breast Cancer"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-17-0754","volume":"23","author":"Dickler","year":"2017","journal-title":"Clin Cancer Res"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1505270","volume":"373","author":"Turner","year":"2015","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/jnci\/93.9.684","volume":"93","author":"Fisher","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","volume":"34","author":"Chirgwin","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1200\/JCO.2015.62.3504","volume":"34","author":"Colleoni","year":"2016","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/JCO.20.02514","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1093\/annonc\/mdt195","volume":"24","author":"Wouters","year":"2013","journal-title":"Ann Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3747\/co.27.6131","volume":"27","author":"Lipton","year":"2020","journal-title":"Curr Oncol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5106","DOI":"10.1111\/1475-6773.13014","volume":"53","author":"Ritzwoller","year":"2018","journal-title":"Health Serv Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41687-019-0114-5","volume":"3","author":"Gast","year":"2019","journal-title":"J Patient Rep Outcomes"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.clbc.2017.08.005","volume":"18","author":"Kool","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"310804","DOI":"10.1155\/2012\/310804","volume":"2012","author":"Barisic","year":"2012","journal-title":"J Cancer Epidemiol"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=67789","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=67789","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T20:40:49Z","timestamp":1616013649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/patient-oncologist-and-payer-preferences-for-adjuvant-endocrine-therap-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2147\/ppa.s298670","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}